EUVIMEDEUVIMED entdecken
Crossref

Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson’s Disease in Rats

Monalisa Rout, Shakti Ketan Prusty, Vishal Singh, Sneha Kispotta, Prerana Sarangi, Durga Madhab Kar

Neurochemical Research · 2026-04 · 51 (2)

DOI: 10.1007/s11064-026-04698-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 23.02.2026. Verfasst von Monalisa Rout und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences-II, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Bacillus coagulans, Brain-Gut Axis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota and its derived metabolites affect brain physiology through several pathways. Dysfunction of gut-microbiota is involved in the pathogenesis of Parkinson's disease (PD). Introduced the pleiotropic effect of probiotics (PBT) in the function of the central nervous system, can delay the disease progression through microbiota-gut-brain axis (MGBA). PD is characterized by aggregated alpha-synuclein (α-syn), oxidative stress and neuroinflammation leading to depletion of dopaminergic neurons in the midbrain region. Our study designed to assess the neuroprotective effect of PBT Bacillus coagulans (B. coagulans) against rotenone (ROT) induced PD rats. To eliminate hormone-based errors associated with estrous cycle, we only used male rats in this experiment. ROT (50 mg/kg/day) caused perturbation of intestinal barrier leading to gut microbiome disturbances along with accumulation of α-syn in intestine and brain with motor deficits. qPCR of gut homogenate interpreted that treatment with B. coagulans alter the gut microbial composition in experimental PD through MGBA. This formulation claims as a supportive agent to restore the progression and aid in the therapeutic management of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProbioticsBacillus coagulansBrain-Gut AxisBrainNeuroprotective AgentsParkinson Disease, SecondaryAnimalsRotenoneMaleRatsalpha-SynucleinRats, WistarParkinson Disease

Stichwörter der Autor:innen

B. coagulansGut microbiotaGut-brain axisParkinson’s diseaseProbiotics

Substanzen

Rotenonealpha-SynucleinNeuroprotective Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences-II, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, India.
  • School of Pharmaceutical Sciences, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, India.
  • School of Pharmaceutical Sciences-II, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, India. durgamadhabkar@soa.ac.in.

Zitieren

APA

Rout, M., Prusty, S. K., Singh, V., Kispotta, S., Sarangi, P., & Kar, D. M. (2026). Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson’s Disease in Rats. Neurochemical Research, 51(2). https://doi.org/10.1007/s11064-026-04698-7

Vancouver

Rout M, Prusty SK, Singh V, Kispotta S, Sarangi P, Kar DM. Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson’s Disease in Rats. Neurochemical Research. 2026;51(2). doi:10.1007/s11064-026-04698-7

BibTeX
@article{Rout2026,
  author = {Rout, Monalisa and Prusty, Shakti Ketan and Singh, Vishal and Kispotta, Sneha and Sarangi, Prerana and Kar, Durga Madhab},
  title = {Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson’s Disease in Rats},
  journal = {Neurochemical Research},
  year = {2026},
  volume = {51},
  number = {2},
  doi = {10.1007/s11064-026-04698-7}
}
Kostenlos starten →